Leerink Partners Starts AnaptysBio (ANAB) at Outperform
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $57.77 +3.12%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Partners analyst David Risinger initiates coverage on AnaptysBio (NASDAQ: ANAB) with a Outperform rating and a price target of $47.00.
For an analyst ratings summary and ratings history on AnaptysBio click here. For more ratings news on AnaptysBio click here.
Shares of AnaptysBio closed at $21.27 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
